Works matching IS 21579024 AND DT 2018 AND VI 7 AND IP 1
Results: 11
Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0025-3
- By:
- Publication type:
- Article
HNRNPH1 is required for rhabdomyosarcoma cell growth and survival.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0024-4
- By:
- Publication type:
- Article
Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0023-5
- By:
- Publication type:
- Article
Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0022-6
- By:
- Publication type:
- Article
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0021-7
- By:
- Publication type:
- Article
Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0020-8
- By:
- Publication type:
- Article
LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0019-1
- By:
- Publication type:
- Article
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0017-3
- By:
- Publication type:
- Article
Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0013-7
- By:
- Publication type:
- Article
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0018-2
- By:
- Publication type:
- Article
The hypoxic tumour microenvironment.
- Published in:
- Oncogenesis, 2018, v. 7, n. 1, p. 1, doi. 10.1038/s41389-017-0011-9
- By:
- Publication type:
- Article